Apply for a Welter Family graduate fellowship for research on Cystic Fibrosis
Applications are due August 13, 2021.
Recently, the Welter Family started an endowment aimed at facilitating discoveries in
cystic fibrosis research, which can include mechanistic studies, drug development,
and/or related diseases that affect those with CF (eg., infections of the lung). The Welter
…
Sean Cocchia Rare Disease Research Grant Opportunity
Applications due April 1, 2021.
Thanks to a gift from a benefactor, Sean Cocchia, we are offering one-time grants (up to $25,000) for research aimed at facilitating discoveries in rare disease research, which can include and is not limited to mechanistic studies, drug development, and/or related processes. The grants will provide financial support to conduct research during the 2020-2021 academic year. I ask that you disseminate this request for applications to members of your research team and other groups that you feel qualified to work in this area of research.…
Leahy-Filipi Family Endowment for Excellence in Neuroscience Research
Funding is available through the Leahy-Filipi Family, Notre Dame alumni, to support research in neuroscience. This fellowship will provide a $10,000 fellowship.
.
Overall Goals of Leahy Filipi Family Endowment for Excellence in Neuroscience Research: …
The Warren Center for Drug Discovery invites new proposals for projects that are associated with drug discovery. In particular, projects associated with small molecule synthesis (libraries or molecular probes), hit validation, lead optimization, mid-sized scale up, assay development, protein purification, and ADMET screening. Any disease areas will be considered. Collaborative opportunities exist for the preparation of small molecules and/or computational-derived drug discovery via three cores: Chemical Synthesis & Drug Discovery, Computer-Aided Molecular Design, or Biological Screening and Development core. …
Veronica Hubble, a graduate student in the Melander lab, is the first recipient of the Welter Family graduate fellowship for research on Cystic Fibrous. The Welter Family Fellowship in Science provides financial support to conduct research during the 2019 academic year. This fellowship is aimed at facilitating discoveries in cystic fibrosis research, which can include mechanistic studies, drug development, and/or related diseases that affect those with CF (eg. infections of the lung). Veronica’s proposal was entitled “Using small molecule adjuvants to combat antibiotic resistant bacteria in cystic fibrosis.”…
Members of the Warren Center in attendance at the annual Ara Parseghian Medical Research Conference in Tucson, AZ in early June.
…
As the 2018 academic year comes to an end, a summary of this year's accomplishments is provided in the annual Warren Roundup. First of all, several lead compounds have been identified by Notre Dame researchers and are undergoing preclinical evaluation, in hopes of identifying investigational new drugs (IND) for clinical evaluation. …
Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.
University of Notre Dame licensee Hsiri Therapeutics, Inc., with its corporate headquarters located in Media, PA, has entered into a license agreement with Shionogi & Co., Ltd. regarding a collaborative licensing, research and development program to discover and develop novel therapeutics for non-tuberculous mycobacterial (NTM…
In America, more than a million people suffer from diabetic foot ulcers.
In Latin, SalvePeds means “saving feet.”
And in SalvePeds, a new IDEA Center startup managed and marketed by a team of graduate students at the University of Notre Dame, patients may soon have a more effective option to treat diabetic foot ulcers and prevent some of the 100,000 amputations the condition necessitates every year.…
Welcome to the first edition of the Warren Roundup, wherein an attempt is made to summarize accomplishments by members of the Warren Family Research Center for Drug Discovery. In addition, you will find below a succinct summary of the services provided by each of the three scientific cores (synthesis, computational, and biological). Not only do I invite you to provide updates for inclusion in upcoming issues, but I also encourage you to learn more about the Warren Center cores and how they can help expedite your research.…
The Indiana Clinical and Translational Sciences Institute (CTSI), a research partnership among Indiana University, Purdue University and the University of Notre Dame, has launched a new program called “All IN for Health” to help grow public awareness of the state’s current health challenges and to invite the public’s participation into research studies taking place at our academic partner institutions.